HCA Healthcare stock rises after a 4.9 percent gain
Published on 09/11/2026 at 20:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
HCA Healthcare stock (ISIN US40412C1018) closed at USD 422.47 on the NYSE on September 10, 2026, after a 4.9 percent gain. The move came as MarketBeat said the stock had a Moderate Buy consensus and an average price target of USD 462.64 on September 11, 2026.
Quarterly numbers stay solid
MarketBeat also said HCA Healthcare reported adjusted EPS of USD 7.59 and revenue of USD 20.23 billion, both for the latest quarter it cited. The same report put the year-earlier EPS at USD 6.84 and showed that the latest EPS beat the consensus estimate of USD 7.56 by USD 0.03.
The revenue comparison is equally clear: USD 20.23 billion topped the USD 19.76 billion estimate in that report. MarketBeat also noted a quarterly dividend of USD 0.78 per share, equal to a 0.7 percent yield, with the ex-dividend date set for September 16, 2026.
Valuation remains the focus
The most important market anchor is the gap between the September 10 close of USD 422.47 and the MarketBeat average target of USD 462.64. That leaves the stock about USD 40.17 below the consensus level, while the reported market capitalization stood at USD 91.32 billion on September 11, 2026.
For investors, the mix of USD 7.59 in adjusted EPS, USD 20.23 billion in revenue and a 4.9 percent daily gain keeps valuation and follow-through in the spotlight.
Stock level and key data
HCA Healthcare stock traded at USD 422.47 on September 10, 2026, on the NYSE. MarketBeat's snapshot on September 11, 2026 also listed a market capitalization of USD 91.32 billion and a PEG ratio of 1.39.
HCA Healthcare stock key data
- Company: HCA Healthcare, Inc.
- ISIN: US40412C1018
- Ticker: HCA
- Trading venue: NYSE
- Price (as of September 10, 2026): USD 422.47
- Market capitalization: USD 91.32 billion (as of September 11, 2026)
- Sector / Industry: Healthcare / Hospitals and Health Care
- Index membership: S&P 500
